期刊文献+

超高效液相色谱法测定非布司他片的溶出度

Dissolution Determination of Febuxostat Tablets By UPLC
下载PDF
导出
摘要 目的:建立超高效液相色谱法测定非布司他片溶出度的方法。方法:采用桨法,p H6.8的磷酸盐缓冲液为溶出介质,转速为每分钟50转,30 min取样,采用超高效液相色谱法测定非布司他的溶出量。结果:在5.05~80.80μg·m L-1浓度范围内呈良好的线性关系(r=0.9999),平均回收率为100.24%。3批样品在30min时的溶出度均超过标示量的80%。f2因子测定结果表明3批制剂与1批市售制剂的溶出过程相似。结论:本方法简便、快速、准确,适合测定非布司他片的溶出度。 Objective:To establish a method of the dissolution determination of Febuxostat tablets. Method:Paddle method was adopted. Using phosphate buffer with p H=6.8 as the solvent,the rotation speed at 50 r·min-1,UPLC method was used to determine the content. Result:The assay displayed a good linearity over the concentration range of 5.05~80.80μg·m L-1(r=0.9999),the average recoverywas 100.24%. f2 of self-made products and commercial product showed that their dissolution procedure were similar. Conclusion:The method is rapid and accurate. It can be applied to determine dissolution of Febuxostat tablets.
作者 陆晶
出处 《黑龙江医药》 CAS 2015年第2期211-213,共3页 Heilongjiang Medicine journal
关键词 非布司他片 溶出度 超高效液相色谱法 Febuxostat tablets Dissolution UPLC
  • 相关文献

参考文献2

二级参考文献24

  • 1MASSEY V, KOMAI H, PALMERr G, et al. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[ 3,4-d ] pyrimidines [ J ]. J Biol Chem, 1970, 245 ( 11 ) :2837 - 2844.
  • 2HORIUCHI H, OTA M, NISHIMURA S, et al. Allopurinol induces renal toxicity by impairing pyrimidine[J]. Life Sci, 2000, 66(21) :2051 -2070.
  • 3TAKANOB Y, HASE-AOKI K, HORIUCHI H, et al. Selectivity of febuxostat, a novel non-purine inhibitor of xanthlne oxidase/ xanthine dehydrogenase [ J ]. Life Sci, 2005, 76 (16) : 1835 - 1847.
  • 4OSADA Y, TSUCHIMOTO M, FUKUSHIMA H, et al. Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents[J]. Eur J Pharmacol, 1993, 241(2-3) :183-188.
  • 5HORIUCHI H, OTA M, KOBAYASHI M, et al. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats[ J]. Res Commun Mol Pathol Pharmacol, 1999, 104 ( 3 ) :307 - 319.
  • 6KOMORIYA K, OSADA Y, HASEGAWA M, et al. Hypouricemic effect of allopurinol and the novel xanthine oxldase inhibitor TE145720 in chimpanzees [ J ]. Eur J Pharmacol, 1993, 250 (3) :455 -460.
  • 7GRABOWSKI BA, VERNILLET L, KHOSRAVAN R, et al. Metabolism and excretion of [ ^14C ] febuxostat, a novel non-purine selective inhibitor of xanthine oxidase, in healthy male subjects [ J ]. Drug Metab Rev, 2005, 37 ( Suppl 2) : S111.
  • 8KHOSRAVAN R, KUKULKA M, WU JT, et al. The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase[J]. J Clin Pharmacol, 2008, 48 : 1014 - 1025.
  • 9KHOSRAVAN R, GRABOWSKI BA. , WU JT, et al. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a nonpurine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects [ J ]. Clin Pharmacokinet, 2006, 45 (8) :821 -841.
  • 10KHOSRAVAN R, GRABOWSKI, B, WU JT, et al. Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects[ J]. Br J Clin Pharmacol, 2008, 65 (3) :355 -363.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部